A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features

Molecular Vision

Volumn 17, Issue , 2011, Pages 1669-1678

  Brézin, Antoine P ^a   Nedelec, Brigitte ^b   Barjol, Amandine ^a   Rothschild, Pierre Raphael ^b   Delpech, Marc ^b,c   Valleix, Sophie ^b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOTHERAPY; DISEASE ASSOCIATION; FAMILIAL DISEASE; FEMALE; GENE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC TRANSCRIPTION; HUMAN; LASER COAGULATION; MOLECULAR GENETICS; OPHTHALMOLOGY; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RETINA DETACHMENT; RNA SPLICING; UVEITIS; VCAN GENE; VITREORETINOPATHY; WAGNER DISEASE;

CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRANCE; GENETIC ASSOCIATION STUDIES; GENETIC TESTING; GENOTYPE; HUMANS; INTRONS; MALE; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PEDIGREE; PHENOTYPE; RETINAL DEGENERATION; RETINAL DETACHMENT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICE SITES; RNA SPLICING; VERSICANS; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 79959964877     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Graemiger RA, Niemeyer G, Schneeberger SA, Messmer EP. Wagner vitreoretinal degeneration. Follow-up of the original pedigree. Ophthalmology 1995; 102:1830-1839. [PMID: 9098284]
2. Wagner H. Ein bisher unbekanntes Erbleiden des Auges (degeneratiohyaloideo-retinalis hereditaria), beobachtet im Kanton Zurich. Klin Mbl Augenheilk 1938; 100:840-857.
3. Stickler GB, Belau PG, Farrell FJ, Jones JD, Pugh DG, Steinberg AG, Ward LE. Hereditary progressive arthroophthalmopathy. Mayo Clin Proc 1965; 40:433-455. [PMID: 14299791]
4. Black GC, Perveen R, Wiszniewski W, Dodd CL, Donnai D, McLeod D. A novel hereditary developmental vitreoretinopathy with multiple ocular abnormalities localizing to a 5-cM region of chromosome 5q13-q14. Ophthalmology 1999; 106:2074-2081. [PMID: 10571340]
5. Brown DM, Graemiger RA, Hergersberg M, Schinzel A, Messmer EP, Niemeyer G, Schneeberger SA, Streb LM, Taylor CM, Kimura AE. Genetic linkage of Wagner disease and erosive vitreoretinopathy to chromosome 5q13-14. Arch Ophthalmol 1995; 113:671-675. [PMID: 7748141]
6. Brown DM, Kimura AE, Weingeist TA, Stone EM. Erosive vitreoretinopathy. A new clinical entity. Ophthalmology 1994; 101:694-704. [PMID: 8152765]
7. Mukhopadhyay A, Nikopoulos K, Maugeri A, de Brouwer AP, van Nouhuys CE, Boon CJ, Perveen R, Zegers HA, Wittebol-Post D, van den Biesen PR, van der Velde-Visser SD, Brunner HG, Black GC, Hoyng CB, Cremers FP. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants. Invest Ophthalmol Vis Sci 2006; 47:3565-3572. [PMID: 16877430]
8. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002; 14:617-623. [PMID: 12231358]
9. Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB. The interaction of versican with its binding partners. Cell Res 2005; 15:483-494. [PMID: 16045811]
10. Dours-Zimmermann MT, Zimmermann DR. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 1994; 269:32992-32998. [PMID: 7806529]
11. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 1995; 270:958-965. [PMID: 7822336]
12. Zako M, Shinomura T, Ujita M, Ito K, Kimata K. Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues. J Biol Chem 1995; 270:3914-3918. [PMID: 7876137]
13. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995; 121:2303-2312. [PMID: 7671797]
14. Schmalfeldt M, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR. Versican V2 is a major extracellular matrix component of the mature bovine brain. J Biol Chem 1998; 273:15758-15764. [PMID: 9624174]
15. Cattaruzza S, Schiappacassi M, Ljungberg-Rose A, Spessotto P, Perissinotto D, Mörgelin M, Mucignat MT, Colombatti A, Perris R. Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem 2002; 277:47626-47635. [PMID: 12221092]
16. Perissinotto D, Iacopetti P, Bellina I, Doliana R, Colombatti A, Pettway Z, Bronner-Fraser M, Shinomura T, Kimata K, Mörgelin M, Löfberg J, Perris R. Avian neural crest cell migration is diversely regulated by the two major hyaluronanbinding proteoglycans PG-M/versican and aggrecan. Development 2000; 127:2823-2842. [PMID: 10851128]
17. Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 2000; 113:807-816. [PMID: 10671370]
18. Zako M, Shinomura T, Miyaishi O, Iwaki M, Kimata K. Transient expression of PG-M/versican, a large chondroitin sulfate proteoglycan in developing chicken retina. J Neurochem 1997; 69:2155-2161. [PMID: 9349562]
19. Kloeckener-Gruissem B, Bartholdi D, Abdou MT, Zimmermann DR, Berger W. Identification of the genetic defect in the original Wagner syndrome family. Mol Vis 2006; 12:350-355. [PMID: 16636652]
20. Meredith SP, Richards AJ, Flanagan DW, Scott JD, Poulson AV, Snead MP. Clinical characterisation and molecular analysis of Wagner syndrome. Br J Ophthalmol 2007; 91:655-659. [PMID: 17035272]
21. Miyamoto T, Inoue H, Sakamoto Y, Kudo E, Naito T, Mikawa T, Mikawa Y, Isashiki Y, Osabe D, Shinohara S, Shiota H, Itakura M. Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. Invest Ophthalmol Vis Sci 2005; 46:2726-2735. [PMID: 16043844]
22. Ronan SM, Tran-Viet KN, Burner EL, Metlapally R, Toth CA, Young TL. Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome. Arch Ophthalmol 2009; 127:1511-1519. [PMID: 19901218]
23. Poulter JA, Ali M, Gilmour DF, Rice A, Kondo H, Hayashi K, Mackey DA, Kearns LS, Ruddle JB, Craig JE, Pierce EA, Downey LM, Mohamed MD, Markham AF, Inglehearn CF, Toomes C. Mutations in TSPAN12 cause autosomaldominant familial exudative vitreoretinopathy. Am J Hum Genet 2010; 86:248-253. [PMID: 20159112]
24. Qin M, Hayashi H, Oshima K, Tahira T, Hayashi K, Kondo H. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/ or FZD4 genes. Hum Mutat 2005; 26:104-112. [PMID: 15981244]
25. Kenagy RD, Plaas AH, Wight TN. Versican degradation and vascular disease. Trends Cardiovasc Med 2006; 16:209-215. [PMID: 16839865]
26. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS, Yang BB. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 2004; 18:754-756. [PMID: 14766798]
27. Wang W, Xu GL, Jia WD, Ma JL, Li JS, Ge YS, Ren WH, Yu JH, Liu WB. Ligation of TLR2 by versican: a link between inflammation and metastasis. Arch Med Res 2009; 40:321-323. [PMID: 19608024]
28. Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J Comput Biol 1997; 4:311-323. [PMID: 9278062]